T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma

This study is testing a new chemotherapy oil preparation (T-ACE Oil) delivered directly to a liver tumor through its blood supply (a procedure called TAE or TACE — trans-arterial embolization/chemoembolization). The goal is to see if this new formulation improves outcomes in people with liver cancer. **You may be eligible if:** - You are 20 or older - You have been diagnosed with hepatocellular carcinoma (HCC, a type of liver cancer), confirmed by biopsy or imaging - Your cancer is at an early to intermediate stage (BCLC staging), with no more than 10 tumors and no tumor larger than 15 cm - Your liver function is still reasonably preserved - Your cancer is suitable for treatment through the blood vessels (TAE/TACE) **You may NOT be eligible if:** - Your liver function is too poor for the procedure - Your cancer is too advanced for TAE/TACE - You need more than one treatment session during the study Talk to your doctor to see if this trial is right for you.